Pasithea Therapeutics (KTTA) Stock Chart & Stock Price History $0.72 +0.01 (+0.70%) Closing price 03:54 PM EasternExtended Trading$0.72 +0.01 (+0.96%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pasithea Therapeutics Stock Price Performance The Pasithea Therapeutics (KTTA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.74%, with a year-to-date return of -77.23%. In the past month, the stock has decreased 0.40%, reflecting recent market activity. As of the latest close, Pasithea Therapeutics traded at $0.71 with a market cap of $5.30 million and volume of 35,301 shares. Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.05%1 Month Performance-0.40%3 Month Performance-23.79%Year-To-Date Performance-77.23%1 Year Performance-84.74% KTTA Stock Chart for Friday, August, 22, 2025 KTTA Chart by TradingView Pasithea Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.71$0.71+0.98%$0.72$0.6935,301 shs$5.30 million08/20/2025$0.71$0.71-0.96%$0.73$0.6924,340 shs$5.25 million08/19/2025$0.71$0.71+0.13%$0.73$0.7080,398 shs$5.30 million08/18/2025$0.70$0.71+1.20%$0.73$0.6983,389 shs$5.29 million08/15/2025$0.70$0.70$0.71$0.6736,617 shs$5.23 million08/14/2025$0.72$0.70-2.13%$0.72$0.6973,370 shs$5.23 million08/13/2025$0.70$0.72+2.57%$0.72$0.68105,735 shs$5.34 million08/12/2025$0.68$0.70+3.17%$0.71$0.6662,481 shs$5.21 million08/11/2025$0.68$0.68-0.51%$0.72$0.6852,521 shs$5.05 million08/08/2025$0.70$0.68-2.57%$0.72$0.6592,343 shs$5.08 million Get the Latest News and Ratings for KTTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$0.69$0.70+2.19%$0.71$0.6845,305 shs$5.21 million08/06/2025$0.70$0.69-1.58%$0.70$0.6762,684 shs$5.10 million08/05/2025$0.71$0.70-1.97%$0.70$0.6819,698 shs$5.18 million08/04/2025$0.70$0.71+1.69%$0.73$0.6943,676 shs$5.28 million08/01/2025$0.73$0.70-4.36%$0.73$0.6876,724 shs$5.20 million07/31/2025$0.73$0.73-0.19%$0.75$0.71327,599 shs$5.43 million07/30/2025$0.73$0.73+0.26%$0.79$0.69169,976 shs$5.45 million07/29/2025$0.75$0.73-2.11%$0.76$0.7192,798 shs$5.43 million07/28/2025$0.73$0.75+2.64%$0.75$0.70130,622 shs$5.54 million07/25/2025$0.74$0.73-1.40%$0.74$0.71111,789 shs$5.40 million07/24/2025$0.72$0.74+2.24%$0.75$0.72102,866 shs$5.48 million07/23/2025$0.72$0.72+0.03%$0.73$0.6837,718 shs$5.36 million07/22/2025$0.71$0.72+2.10%$0.73$0.6887,566 shs$5.36 million07/21/2025$0.72$0.71-2.06%$0.73$0.7044,475 shs$5.25 million Related Companies 180 Life Sciences Stock Price Chart Aytu BioPharma Stock Price Chart Finch Therapeutics Group Stock Price Chart Moleculin Biotech Stock Price Chart Relmada Therapeutics Stock Price Chart Passage Bio Stock Price Chart Pulmatrix Stock Price Chart Aspire Biopharma Stock Price Chart Chemomab Therapeutics Stock Price Chart Dare Bioscience Stock Price Chart Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access